TIME Names Stablepharma’s Fridge-Free Vaccine a Best Invention of 2026

SPVX02 recognised in TIME’s Medical & Healthcare category as Stablepharma advances its temperature-stable tetanus-diphtheria vaccine into a pivotal Phase 2b clinical trial London, UK, 15 October 2026 – Stablepharma Ltd, a biotechnology company developing temperature-stable vaccines and pharmaceuticals, today announced that its lead vaccine candidate, SPVX02, has been named one of TIME’s Best Inventions of […]

Read More